A Study of Amivantamab Monotherapy in Participants With Previously Treated Advanced Hepatocellular Carcinoma

NCT05653427 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
18
Enrollment
INDUSTRY
Sponsor class

Stopped N\~15 subjects data analysis did not meet statistical consideration of ORR and study primary/secondary objectives were not met. Enrollment was terminated for futility

Conditions

Interventions

Sponsor

Janssen Research & Development, LLC